The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Consolidative high dose chemotherapy and autologous stem cell transplant for patients with primary central nervous system lymphoma using thiotepa, busulfan, and cyclophosphamide conditioning regimen.
 
Patricia Ann Young
Research Funding - CTI BioPharma Corp (Inst); ImmunGene (Inst)
 
Davis Kipkemboi Kimaiyo
No Relationships to Disclose
 
John P Chute
No Relationships to Disclose
 
Gary J. Schiller
Research Funding - Medimmune
 
John Timmerman
Stock and Other Ownership Interests - Biomarin; Medivation
Honoraria - Bristol-Myers Squibb; Ono Pharmaceutical
Consulting or Advisory Role - Celgene; Genmab; Seagen
Research Funding - Bristol-Myers Squibb; ImmunGene; Janssen Oncology; Kite, a Gilead company; Merck
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Sven De Vos
Consulting or Advisory Role - Bayer; Genentech; Incyte
 
Herbert Aaron Eradat
Honoraria - Abbvie; Genentech/Roche; Gilead Sciences
Consulting or Advisory Role - Abbvie; Genentech/Roche; Gilead Sciences
Speakers' Bureau - Abbvie; Genentech/Roche; Gilead Sciences; Pharmacyclics
Research Funding - Abbvie; Celgene; Genentech/Roche; Gilead Sciences; miRagen; Pharmacyclics; Seagen